Co-Diagnostics, Inc. (CODX)

↓ Download CSV

CIK 0001692415 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Dec 31

In fiscal 2025, Co-Diagnostics, Inc. reported revenue of $622.5K, down 84.1% from the prior year. The company ran a net loss, with a net margin of -7533.6% and a gross margin of 64.3%. It held $24.74M in total assets against $4.11M in total liabilities.

Key ratios (FY2025)

64.3%
Gross margin
-8058.8%
Operating margin
-7533.6%
Net margin
-227.3%
Return on equity
-84.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$622.5K$3.92M$6.81M$34.22M$97.89M$74.55M$215.0K$39.9K$7.7K
Cost of Revenue$222.4K$999.1K$4.18M$5.48M$11.57M$16.59M$112.4K$9.4K$302
Gross Profit$400.1K$2.92M$2.63M$28.74M$86.31M$57.96M$102.5K$30.5K$7.4K
Operating Income-$50.17M-$40.08M-$42.71M-$26.98M$46.06M$41.69M-$5.89M-$6.12M-$4.56M-$1.69M
Net Income-$46.90M-$37.64M-$35.33M-$14.24M$36.66M$42.48M-$6.20M-$6.27M-$6.96M-$1.93M
EPS (Diluted)$-35.25$-37.22$-1.20$-0.45$1.23$1.52$-0.37
Total Assets$24.74M$63.56M$95.32M$123.09M$160.03M$71.24M$2.22M$1.55M$4.66M$1.30M
Total Liabilities$4.11M$9.69M$9.31M$8.57M$25.56M$4.54M$478.1K$2.61M$811.8K$4.29M
Shareholders' Equity$20.63M$53.88M$85.58M$114.52M$134.48M$66.70M$1.74M-$1.06M$3.85M-$2.99M
Cash & Equivalents$11.88M$2.94M$14.92M$22.97M$88.61M$42.98M$893.1K$950.2K$3.53M$998.7K
Operating Cash Flow-$29.14M-$29.16M-$22.08M$6.57M$41.08M$28.17M-$5.53M-$4.08M-$3.21M-$1.31M
Capital Expenditures$700.0K$748.4K$1.37M$1.43M$669.5K$774.4K$113.2K$41.3K$129.3K$12.2K
Shares Outstanding2.10M1.10M31.26M30.87M33.82M28.56M17.34M12.92M12.32M9.88M